Cell targeting peptide guided nanomedicine: a new paradigm in precision oncology for the management of non-small cell lung cancer.
The current review elucidates the pathophysiological complexity of NSCLC and prominent overexpressed receptors that can be harnessed for peptide-mediated targeting while critically evaluating the applications of CTP-functionalized NCs in chemotherapy, immunotherapy, phototherapy, gene delivery and tumor imaging.